1491 related articles for article (PubMed ID: 30728504)
1. Anti-tumour immunity controlled through mRNA m
Han D; Liu J; Chen C; Dong L; Liu Y; Chang R; Huang X; Liu Y; Wang J; Dougherty U; Bissonnette MB; Shen B; Weichselbaum RR; Xu MM; He C
Nature; 2019 Feb; 566(7743):270-274. PubMed ID: 30728504
[TBL] [Abstract][Full Text] [Related]
2. Methionine deficiency facilitates antitumour immunity by altering m
Li T; Tan YT; Chen YX; Zheng XJ; Wang W; Liao K; Mo HY; Lin J; Yang W; Piao HL; Xu RH; Ju HQ
Gut; 2023 Mar; 72(3):501-511. PubMed ID: 35803704
[TBL] [Abstract][Full Text] [Related]
3. N
Wang Y; Jin P; Wang X
Apoptosis; 2024 Feb; 29(1-2):142-153. PubMed ID: 37698736
[TBL] [Abstract][Full Text] [Related]
4. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
5. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
6. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
[TBL] [Abstract][Full Text] [Related]
7. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
[TBL] [Abstract][Full Text] [Related]
8. Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells.
Bai X; Wong CC; Pan Y; Chen H; Liu W; Zhai J; Kang W; Shi Y; Yamamoto M; Tsukamoto T; Nomura S; Chiu P; Yu J; Kwok-Wai Ng E
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35193930
[TBL] [Abstract][Full Text] [Related]
9. NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.
Iraolagoitia XL; Spallanzani RG; Torres NI; Araya RE; Ziblat A; Domaica CI; Sierra JM; Nuñez SY; Secchiari F; Gajewski TF; Zwirner NW; Fuertes MB
J Immunol; 2016 Aug; 197(3):953-61. PubMed ID: 27342842
[TBL] [Abstract][Full Text] [Related]
10. YTHDF1-regulated expression of TEAD1 contributes to the maintenance of intestinal stem cells.
Jiang D; Hou J; Qian Y; Gao Y; Gao X; Wei S
Biochem Biophys Res Commun; 2021 Jun; 557():85-89. PubMed ID: 33862464
[TBL] [Abstract][Full Text] [Related]
11. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.
Uhl M; Kepp O; Jusforgues-Saklani H; Vicencio JM; Kroemer G; Albert ML
Cell Death Differ; 2009 Jul; 16(7):991-1005. PubMed ID: 19229247
[TBL] [Abstract][Full Text] [Related]
12. Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.
Giampazolias E; Schulz O; Lim KHJ; Rogers NC; Chakravarty P; Srinivasan N; Gordon O; Cardoso A; Buck MD; Poirier EZ; Canton J; Zelenay S; Sammicheli S; Moncaut N; Varsani-Brown S; Rosewell I; Reis e Sousa C
Cell; 2021 Jul; 184(15):4016-4031.e22. PubMed ID: 34081922
[TBL] [Abstract][Full Text] [Related]
13. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
[TBL] [Abstract][Full Text] [Related]
14. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
[TBL] [Abstract][Full Text] [Related]
15. Targeting m
Bao Y; Zhai J; Chen H; Wong CC; Liang C; Ding Y; Huang D; Gou H; Chen D; Pan Y; Kang W; To KF; Yu J
Gut; 2023 Aug; 72(8):1497-1509. PubMed ID: 36717220
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes.
Sun NY; Chen YL; Lin HW; Chiang YC; Chang CF; Tai YJ; Chen CA; Sun WZ; Chien CL; Cheng WF
Cancer Lett; 2019 Mar; 444():20-34. PubMed ID: 30543813
[TBL] [Abstract][Full Text] [Related]
17. YTHDF1 Control of Dendritic Cell Cross-Priming as a Possible Target of Cancer Immunotherapy.
Kim DJ; Iwasaki A
Biochemistry; 2019 Apr; 58(15):1945-1946. PubMed ID: 30943019
[No Abstract] [Full Text] [Related]
18. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
[TBL] [Abstract][Full Text] [Related]
19. m
Shi H; Zhang X; Weng YL; Lu Z; Liu Y; Lu Z; Li J; Hao P; Zhang Y; Zhang F; Wu Y; Delgado JY; Su Y; Patel MJ; Cao X; Shen B; Huang X; Ming GL; Zhuang X; Song H; He C; Zhou T
Nature; 2018 Nov; 563(7730):249-253. PubMed ID: 30401835
[TBL] [Abstract][Full Text] [Related]
20. Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens.
Alloatti A; Kotsias F; Pauwels AM; Carpier JM; Jouve M; Timmerman E; Pace L; Vargas P; Maurin M; Gehrmann U; Joannas L; Vivar OI; Lennon-Duménil AM; Savina A; Gevaert K; Beyaert R; Hoffmann E; Amigorena S
Immunity; 2015 Dec; 43(6):1087-100. PubMed ID: 26682983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
